Group Captain Shubhanshu Shukla has become the first Indian to reach the International Space Station (ISS) on the Axiom-4 ...

Nominees this week included students from Mishawaka High, Saint Joseph High, Marian High and Elkhart High School Freshman Division. Check back on Monday for next week's nominees!

As Pride Month comes to a close, spend its final weekend celebrating in one of Indy's most historic neighborhoods. What's happening: The 4th annual Irvington Pride will present live music, food stalls ...

Seismic Dance Event has announced the phase one lineup for its 8.0 edition, taking place this November at Austin's acclaimed ...

A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...

When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...

A senior scientist at the U.S. Centers for Disease Control and Prevention has resigned, warning that changes in leadership ...

MacDonald and MacVicar, who were recognized during the recent athletic awards dinner, represented Charlottetown-based Colonel ...

Eli Lilly is the most likely healthcare stock to reach a $1 trillion valuation, and I believe it could hit that plateau by 2027. Eli Lilly's stock has surged close to 400% in five years.

Eli Lilly down 19% in May, worst month since 2009. Underperformed S&P 500 by 24%, worst since August 2000. June shows promise, historically Lilly’s strongest month. See how Matt Maley is ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain medicine.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.